The Biomed Today Webinar: PROTAC Drug Design — Live Q&A brings together researchers, industry experts, and curious learners to explore one of the most promising frontiers in modern drug discovery. PROTACs (Proteolysis-Targeting Chimeras) represent a revolutionary approach that goes beyond traditional inhibition by enabling the targeted degradation of disease-causing proteins.
In this interactive session, attendees will gain a clear understanding of how PROTAC technology works, its advantages over conventional small-molecule therapies, and its growing impact in areas such as cancer and neurodegenerative diseases. The webinar will cover key design principles, challenges in development, and recent breakthroughs shaping the future of targeted therapeutics.
A major highlight of the event is the live Q&A segment, where participants can directly engage with experts, ask questions, and gain practical insights into real-world applications. Whether you are a student, researcher, or industry professional, this session offers valuable knowledge tailored to all levels of expertise.
Join us to stay ahead in the rapidly evolving field of drug design and discover how PROTACs are redefining precision medicine. Don’t miss this opportunity to learn, interact, and be part of the next wave of biomedical innovation.
